George H Yoo
Overview
Explore the profile of George H Yoo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
651
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chow E, Sandercott N, Yoo O, Coyle C, Johnson J, Chung M, et al.
Cancer Rep (Hoboken)
. 2023 Jun;
6(9):e1853.
PMID: 37356968
Background: As the ongoing public health crisis from Coronavirus Disease 2019 (COVID-19) pandemic puts strains on current models of cancer care, many health care centers had to adapt to minimize...
2.
Moentmann M, Johnson J, Chung M, Yoo O, Lin H, Yoo G
J Surg Oncol
. 2021 Sep;
125(2):101-106.
PMID: 34562269
Introduction: This article reports on the effects of an early outbreak during the COVID-19 pandemic on visit volume and telehealth use by various specialists at a comprehensive cancer center. Materials...
3.
Moentmann M, Miller R, Chung M, Yoo G
J Telemed Telecare
. 2021 Feb;
29(5):331-348.
PMID: 33535916
Objectives: As the coronavirus 2019 pandemic puts strains on current models of otolaryngology practice, telemedicine is an attractive way for otolaryngologists to reduce in-person appointments while still addressing the health...
4.
Cole D, Svider P, Shenouda K, Lee P, Yoo N, McLeod T, et al.
Exp Cell Res
. 2019 May;
382(1):111386.
PMID: 31075256
Many FDA-approved anti-cancer therapies, targeted toward a wide array of molecular targets and signaling networks, have been demonstrated to activate the unfolded protein response (UPR). Despite a critical role for...
5.
Shah OBrien P, Xi Y, Miller J, Brownell A, Zeng Q, Yoo G, et al.
J Clin Med
. 2019 May;
8(5).
PMID: 31064122
A paucity of advances in the development of novel therapeutic agents for squamous cell carcinomas of the head and neck, oral cavity (OSCC) and oropharynx, has stagnated disease free survival...
6.
Rozek L, Virani S, Bellile E, Taylor J, Sartor M, Zarins K, et al.
Nutr Cancer
. 2019 Mar;
71(5):772-780.
PMID: 30862188
Aim: Soy isoflavones have been suggested as epigenetic modulating agents with effects that could be important in carcinogenesis. Hypomethylation of LINE-1 has been associated with head and neck squamous cell...
7.
Rayess H, Xi Y, Garshott D, Brownell A, Yoo G, Callaghan M, et al.
Oral Oncol
. 2018 Jan;
76:27-33.
PMID: 29290283
No abstract available.
8.
Rayess H, Dezube A, Bawab I, Raza S, Yoo G, Lin H, et al.
Otolaryngol Head Neck Surg
. 2017 Apr;
157(3):454-461.
PMID: 28397573
Objective The effect of tumor differentiation on prognosis of major salivary gland malignancies is controversial. The aim of this study was to determine the effect of tumor differentiation on prognosis...
9.
Blasco M, Svider P, Tenbrunsel T, Vellaichamy G, Yoo G, Fribley A, et al.
Laryngoscope
. 2017 Apr;
127(6):1345-1350.
PMID: 28397339
Objectives/hypothesis: The incidence of oropharyngeal cancer (OPC) has increased in the United States. This has been driven by an increase in human papillomavirus (HPV)-positive OPC. Our objective is to determine...
10.
Svider P, Blasco M, Raza S, Shkoukani M, Sukari A, Yoo G, et al.
Otolaryngol Head Neck Surg
. 2017 Jan;
156(1):10-13.
PMID: 28045631
Despite a considerable expansion in our therapeutic repertoire for management of other malignancies, mortality from head and neck cancer (HNC) has not significantly improved in recent decades. Upon normalizing National...